it provides investment management and advisory services in the financial markets and investment solutions for a broad array of investors including FIIs, DFI, Insurance companies among other Financial institutions. Business Segments
Systematix Corporate Services has released its Monitoring Agency Report, detailing the use of Rs. 103.12 Cr raised through its Preferential Issue. The company utilized Rs. 25 Cr during the quarter, investing it in subsidiary Systematix Shares and Stocks (India) Limited for working capital, aligning with the offer document. The remaining...
Vivin Drugs & Pharmaceuticals, engaged in pharmaceutical manufacturing, has invited Expressions of Interest for a resolution plan. This move is part of the company's corporate insolvency resolution process. Potential applicants must submit their EOI by August 13. The company's sales stood at Rs 161.36 crore in FY2022-23 and Rs 106.41...
The company's board has approved its financial results, reporting a standalone profit of 5.98 Cr and a consolidated profit of 10.46 Cr for the quarter. They've also approved an Employee Stock Option Scheme (ESOP 2025) for up to 6.83 million shares, with an exercise price offering up to a 30%...
Systematix Group delivered robust financial results for the quarter, reporting consolidated revenues of ₹39.17 Cr, Profit Before Tax of ₹13.87 Cr, and Profit After Tax of ₹10.46 Cr. The company's Investment Banking segment was highly active, facilitating total fundraises of approximately ₹950 Cr via IPOs and block deals during the...
Systematix Corporate Services Limited has submitted a certificate from its Registrar and Share Transfer Agent, Cameo Corporate Services Limited, confirming compliance related to its securities for the quarter ended June 30, 2025. This update reflects routine adherence to shareholding and depository requirements, ensuring smooth corporate governance and investor confidence.
